Brief: Aptevo Therapeutics Says Cash And Cash Equivalents As Of March 31 Totaling $25.3 Mln

Aptevo Therapeutics

11/05/2023 13:19

May 11 (Reuters) - Aptevo Therapeutics Inc  APVO.O :
    * APTEVO THERAPEUTICS - CASH AND CASH EQUIVALENTS AS OF
MARCH 31
TOTALING $25.3 MILLION
    * APTEVO THERAPEUTICS INC - QTRLY EARNINGS PER SHARE $0.39
    * APTEVO THERAPEUTICS INC -  IN Q1 RAISED $9.7 MILLION IN
NON-DILUTIVE FUNDING, EXTENDING CASH RUNWAY BEYOND 12 MONTHS

Source text for Eikon:  ID: 
Further company coverage:  APVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))